Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals

被引:6
作者
Cheedarla, Narayanaiah [1 ]
Precilla, K. Lucia [1 ]
Babu, Hemalatha [1 ]
Vijayan, K. K. Vidya [1 ]
Ashokkumar, Manickam [1 ]
Chandrasekaran, Padmapriyadarsini [1 ]
Kailasam, Nandagopal [2 ]
Sundaramurthi, Jagadish Chandrabose [1 ]
Swaminathan, Soumya [1 ]
Buddolla, Viswanath [3 ]
Vaniambadi, S. Kalyanaraman [4 ]
Ramanathan, V. D. [1 ]
Hanna, Luke Elizabeth [1 ]
机构
[1] Natl Inst Res TB, HIV AIDS Div, Dept Clin Res, Clin Res, Madras 600031, Tamil Nadu, India
[2] Kilpauk Med Coll & Hosp, ART Ctr, Madras 600010, Tamil Nadu, India
[3] Gachon Univ, Dept Bionanotechnol, San 65, Seongnam Si 461701, Gyeonggi Do, South Korea
[4] Adv Biosci Labs Inc, Rockville, MD 20850 USA
关键词
B-CELLS; MONOCLONAL-ANTIBODIES; ENV CLONES; VACCINE; DESIGN; RESPONSES; EPITOPES; INSIGHTS; PG9;
D O I
10.1038/srep46557
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Broadly Cross clade Neutralizing (BCN) antibodies are recognized as potential therapeutic tools and leads for the design of a vaccine that can protect human beings against various clades of Human Immunodeficiency Virus (HIV). In the present study, we screened plasma of 88 HIV-1 infected ART naive individuals for their neutralization potential using a standard panel of 18 pseudoviruses belonging to different subtypes and different levels of neutralization. We identified 12 samples with good breadth of neutralization (neutralized >90% of the viruses). Four of these samples neutralized even the difficult-to-neutralize tier-3 pseudoviruses with great potency (GMT > 600). Analysis of neutralization specificities indicated that four samples had antibodies with multiple epitope binding specificities, viz. CD4-binding site (CD4BS), glycans in the V1/V2 and V3 regions and membrane proximal external region (MPER). Our findings indicate the strong possibility of identifying highly potent bNAbs with known or novel specificities from HIV-1 subtype C infected individuals from India that can be exploited as therapeutic tools or lead molecules for the identification of potential epitopes for design of a protective HIV-1 vaccine.
引用
收藏
页数:13
相关论文
共 55 条
[1]   Neutralization of Tier-2 Viruses and Epitope Profiling of Plasma Antibodies from Human Immunodeficiency Virus Type 1 Infected Donors from India [J].
Andrabi, Raiees ;
Bala, Manju ;
Kumar, Rajesh ;
Wig, Naveet ;
Hazarika, Anjali ;
Luthra, Kalpana .
PLOS ONE, 2012, 7 (08)
[2]   Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption [J].
Bar, K. J. ;
Sneller, M. C. ;
Harrison, L. J. ;
Justement, J. S. ;
Overton, E. T. ;
Petrone, M. E. ;
Salantes, D. B. ;
Seamon, C. A. ;
Scheinfeld, B. ;
Kwan, R. W. ;
Learn, G. H. ;
Proschan, M. A. ;
Kreider, E. F. ;
Blazkova, J. ;
Bardsley, M. ;
Refsland, E. W. ;
Messer, M. ;
Clarridge, K. E. ;
Tustin, N. B. ;
Madden, P. J. ;
Oden, K. S. ;
O'Dell, S. J. ;
Jarocki, B. ;
Shiakolas, A. R. ;
Tressler, R. L. ;
Doria-Rose, N. A. ;
Bailer, R. T. ;
Ledgerwood, J. E. ;
Capparelli, E. V. ;
Lynch, R. M. ;
Graham, B. S. ;
Moir, S. ;
Koup, R. A. ;
Mascola, J. R. ;
Hoxie, J. A. ;
Fauci, A. S. ;
Tebas, P. ;
Chun, T-W .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21) :2037-2050
[3]   Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design [J].
Bonsignori, Mattia ;
Montefiori, David C. ;
Wu, Xueling ;
Chen, Xi ;
Hwang, Kwan-Ki ;
Tsao, Chun-Yen ;
Kozink, Daniel M. ;
Parks, Robert J. ;
Tomaras, Georgia D. ;
Crump, John A. ;
Kapiga, Saidi H. ;
Sam, Noel E. ;
Kwong, Peter D. ;
Kepler, Thomas B. ;
Liao, Hua-Xin ;
Mascola, John R. ;
Haynesa, Barton F. .
JOURNAL OF VIROLOGY, 2012, 86 (08) :4688-4692
[4]   Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design [J].
Burton, Dennis R. ;
Hangartner, Lars .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34, 2016, 34 :635-659
[5]   Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 [J].
Caskey, Marina ;
Klein, Florian ;
Lorenzi, Julio C. C. ;
Seaman, Michael S. ;
West, Anthony P., Jr. ;
Buckley, Noreen ;
Kremer, Gisela ;
Nogueira, Lilian ;
Braunschweig, Malte ;
Scheid, Johannes F. ;
Horwitz, Joshua A. ;
Shimeliovich, Irina ;
Ben-Avraham, Sivan ;
Witmer-Pack, Maggi ;
Platten, Martin ;
Lehmann, Clara ;
Burke, Leah A. ;
Hawthorne, Thomas ;
Gorelick, Robert J. ;
Walker, Bruce D. ;
Keler, Tibor ;
Gulick, Roy M. ;
Faetkenheuer, Gerd ;
Schlesinger, Sarah J. ;
Nussenzweig, Michel C. .
NATURE, 2015, 522 (7557) :487-+
[6]   Neutralization Potential of the Plasma of HIV-1 Infected Indian Patients in the Context of Anti-V3 Antibody Content and Antiretroviral Theraphy [J].
Choudhary, Alok Kumar ;
Andrabi, Raiees ;
Prakash, Somi Sankaran ;
Kumar, Rajesh ;
Choudhury, Shubhasree Dutta ;
Wig, Naveet ;
Biswas, Ashutosh ;
Hazarika, Anjali ;
Luthra, Kalpana .
JOURNAL OF MICROBIOLOGY, 2012, 50 (01) :149-154
[7]   Immune correlates of vaccine protection against HIV-1 acquisition [J].
Corey, Lawrence ;
Gilbert, Peter B. ;
Tomaras, Georgia D. ;
Haynes, Barton F. ;
Pantaleo, Giuseppe ;
Fauci, Anthony S. .
SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (310)
[8]   Lessons Learned from HIV Vaccine Clinical Efficacy Trials [J].
Day, Tracey A. ;
Kublin, James G. .
CURRENT HIV RESEARCH, 2013, 11 (06) :441-449
[9]   HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies [J].
de Taeye, Steven W. ;
Moore, John P. ;
Sanders, Rogier W. .
TRENDS IN IMMUNOLOGY, 2016, 37 (03) :221-232
[10]   In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire [J].
DeKosky, Brandon J. ;
Kojima, Takaaki ;
Rodin, Alexa ;
Charab, Wissam ;
Ippolito, Gregory C. ;
Ellington, Andrew D. ;
Georgiou, George .
NATURE MEDICINE, 2015, 21 (01) :86-91